QualityStocksNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Appoints MBL as Distributor for Nu.Q(R) Discover Assays in Japan
VolitionRx (NYSE American: VNRX), a multi-national epigenetics company, announced the appointment of Medical & Biological Laboratories Co. Ltd. as a non-exclusive distributor of its Nu.Q(R) Discover assays in Japan. The agreement expands access to Volition’s nucleosome-based biomarker assays for drug developers and researchers in the Japanese market and builds on the Company’s growing global collaborator network, as Nu.Q(R) Discover now serves close to 100 clients worldwide, including leading pharmaceutical and diagnostic companies using the assays to support disease research, drug development, and late-stage clinical trials. To view the full press release, visit: https://ibn.fm/dAB9W About Volition Volition is a multi-national company…